The radial access is a viable alternative in infarction complicated with cardiogenic shock

Original title: Arterial access site utilization in cardiogenic shock in the United Kingdom: Is radial access feasible? Reference: Mamas A. Mamas, et al. Am Heart J 2014;167:900-08

Cardiogenic shock in the context of acute myocardial infarction is associated with high mortality, and represents approximately 10% of major bleeding complications. Radial Access reduces mortality mainly by reducing bleeding; however, AMI patients complicated with CS undergoing PCI via radial access have only been assessed in small studies. 

This study analyzed 7231 PCI patients hospitalized with AMI complicated with CS, in UK. 1877 (35%) received radial access and 5354 (64%) femoral access.

Baseline characteristics were similar, although those approached by femoral access site were mostly women, diabetic, requiring higher inotropic support or intraaortic balloon counterpulsation and mechanical ventilation.

Global mortality at 30 days was 36.3% for the whole cohort, 24.7% for the radial access group vs. 39.8% for the femoral access group (p<0.01). This difference was also maintained at 12 months.

After propensity score matching was applied to eliminate possible confusing factors, 1402 patients remained in each group for final analysis, and significant lower mortality was observed in the radial Access group at 30 days (22.8% vs 29.9% p<0.001).

Major bleeding rate was also lower in the radial access group. (1.5% vs 3.5%; p<0.0001). The radial access site resulted an independent predictor of lower event rates at 30 days and this benefit was observed at a time when more than 50% of cases at this center were performed via radial approach. 

Conclusion

Even though most of PCI procedure in CS patients in UK are performed via femoral approach, the radial approach has become a feasible alternative for this high risk population in experienced centers.

Editorial Comment

The safety and efficacy of the radial access site had been shown in other scenarios but it had not been correctly assessed for this group of patients. This study has shown the radial access site is safe and can reduce mayor bleeding and mortality also in the difficult scenario of cardiogenic shock. Nevertheless, it demands highly trained, expert operators. 

Courtesy of Dr. Carlos Fava
Interventional Cardiologist
Favaloro Foundation – Buenos Aires

Dr. Carlos Fava para SOLACI.ORG

More articles by this author

ACC 2026 | ALL-RISE Trial: Coronary Physiological Assessment Using FFRangio

Coronary physiological assessment using pressure-wire techniques (FFR/iFR) carries a Class IA recommendation in ACC/AHA guidelines; however, its use remains limited due to factors such...

ACC 2026 | PRO-TAVI Trial: Deferring Coronary Angioplasty in Patients Undergoing TAVI

Coronary artery disease is common in patients with severe aortic stenosis undergoing TAVI. Current guidelines recommend considering revascularization in significant coronary lesions, particularly in...

ACC 2026 | CHIP-BCIS3: Impella use as support in high-risk complex PCI

The use of percutaneous ventricular support during high-risk complex PCI has been proposed as a strategy to prevent hemodynamic deterioration in patients with severe...

ACC 2026 | ORBITA-CTO: PCI in chronic total occlusions and stable angina — the randomized trial we were missing?

Percutaneous coronary intervention (PCI) for chronic total occlusions (CTO) remains a topic of ongoing debate in stable angina, with persistent uncertainty regarding its role...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2026 | ALL-RISE Trial: Coronary Physiological Assessment Using FFRangio

Coronary physiological assessment using pressure-wire techniques (FFR/iFR) carries a Class IA recommendation in ACC/AHA guidelines; however, its use remains limited due to factors such...

ACC 2026 | Protect The Head-To-Head Trial: Randomized Comparison Between Emboliner and Sentinel During TAVI

Ischemic stroke remains one of the most feared complications of TAVI, with a relatively low but persistent incidence of 2–4%, without significant reduction over...

ACC 2026 | PRO-TAVI Trial: Deferring Coronary Angioplasty in Patients Undergoing TAVI

Coronary artery disease is common in patients with severe aortic stenosis undergoing TAVI. Current guidelines recommend considering revascularization in significant coronary lesions, particularly in...